ArticleVeterinary research2026
TGEV activates RIG-I/IFN-β/STAT1 axis to promote NLRC5-mediated SLA-I upregulation.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Porcine transmissible gastroenteritis virus (TGEV) is a major pathogen causing acute diarrhea and high mortality in neonatal piglets, yet the interplay between TGEV infection and host immune responses, particularly swine leukocyte antigen class I (SLA-I) mediated antigen presentation and type I interferon (IFN) signaling, remains poorly defined. This study aimed to clarify how TGEV modulates SLA-I expression through NOD-like receptor family CARD domain containing 5 (NLRC5) and the underlying signaling pathways. Since TGEV infection was shown to induce SLA-I upregulation in porcine intestinal tissues, we used swine testicular (ST) cells to investigate the expression dynamics of retinoic acid inducible gene I (RIG-I)/IFN-β/signal transducer and activator of transcription 1 (STAT1) axis. TGEV infection significantly upregulated SLA-I and NLRC5 in ST cells, with high expression coinciding with active viral replication, while NLRC5 inhibited TGEV proliferation. Furthermore, TGEV upregulated SLA-I and NLRC5 expression via RIG-I activation, which triggered downstream IFN-β secretion and subsequent STAT1 phosphorylation, thereby facilitating the induction of SLA-I and NLRC5. Moreover, the TGEV open reading frame 7 (ORF7) protein was identified as a critical viral effector contributing to SLA-I and NLRC5 upregulation. Collectively, TGEV infection activates the RIG-I/IFN-β/STAT1 axis to promote NLRC5 mediated SLA-I upregulation, which inhibits TGEV proliferation, elucidating a novel immune regulatory mechanism that balances viral replication and host antiviral defense and providing insights for targeted management strategies against porcine enteric coronaviruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.